RNAi Roundtable: Givosiran, in Development for the Treatment of Acute Hepatic Porphyrias

RNAi Roundtable: Givosiran, in Development for the Treatment of Acute Hepatic Porphyrias

On September 7, 2017, we hosted an online RNAi Roundtable to review the progress with givosiran, an RNAi therapeutic in development for the treatment of acute hepatic porphyrias.

View the presentation

Read the transcript

  • Jae Kim, M.D., Vice President, Clinical Development
  • Moderator: Jeff Miller, General Manager, Givosiran
  • Guest Speaker: Eliane Sardh, M.D., Ph.D., Porphyria Center Sweden, Karolinska University Hospital


SIGN UP FOR PATIENT CONNECT

Receive updates on our investigational therapies and clinical trials.